This signposted external event is not commissioned, organized or facilitated by C&P Training Hub. The availability of these offers are not checked on a daily basis and bookings are done directly with the supplier. You will not be able to see these on your Training Hub Account. Please contact the supplier directly if you have any questions, their contact details should be on your confirmation e-mails.

This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.

Speaker: Trudie Lobban – The Heart Failure Policy Network | The Heart Failure Policy Network

Founder & CEO of Arrhythmia Alliance (A-A), Atrial Fibrillation Association (AF Association), and STARS – Syncope Trust And Reflex Anoxic Seizures

Professional Summary

Visionary healthcare leader and advocate with over 30 years of experience driving awareness, education, and policy change in cardiac rhythm management. Founder of three internationally recognized non-profit organizations—STARS, Arrhythmia Alliance, and the AF Association—that now operate in more than 40 countries. Recognized globally for forging partnerships across clinical, governmental, and patient communities to improve diagnosis, treatment, and quality of life for individuals affected by heart rhythm conditions. Awarded MBE (Member of the British Empire) by HM The Queen (2009) for services to healthcare and appointed Honorary Fellow of the Royal College of Physicians for ongoing contributions to cardiovascular advocacy and patient empowerment.

DaRe2THINK

This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.

Webinar schedule:

12:30 – 12:45 – Presentation by Trudie Lobban MBE

12:45 – 12:55 – Q&A and discussion

12:55 – 13:00 – The DaRe2THINK trial